マーケットレポート詳細
除細動器の世界市場：2028年に至る製品タイプ別、エンドユーザー別予測
Defibrillator Market by Product (Tranvenous ICD (Single & dual chamber, biventricular, CRT-D), Subcutaneous, External (Automated, Wearable)), Patient (Adult, Pediatric), Enduser (Hospitals, Prehospital, Home care, Public Access) - Global Forecast to 2028
- 出版元：MarketsandMarkets
出版元について - 発行年：2023年6月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文211ページになります。
- 商品コード：MAM3289
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
除細動器の世界市場規模は2023年で136億ドル、2028年に181億ドル、市場の平均年成長率は5.9%になると予想されています。
レポートは除細動器の世界市場について2028年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（製品別市場、患者タイプ別市場、等）を中心に構成されています。また競合状況、主要企業情報（20社）、特許分析、ケーススタディ分析などの分析も加味し、除細動器市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆除細動器の世界市場予測2021-2028年
・市場規模(US$)
◆製品別、市場-2028年
植込み型除細動器（ICD）
・経動脈ICD
-両心室ICD/心臓再同期医療機器（CRT）
-デュアルチャンバーICD
-シングルチャンバーICD
・完全皮下植込み型除細動器（S-ICD）
体外式除細動器
・半自動体外式除細動器
・完全自動体外式除細動器
・着用型自動除細動器（WCD）
※(市場規模US$)
◆患者タイプ別、市場-2028年
・成人患者
・小児患者
※(市場規模US$)
◆エンドユーザー別、市場-2028年
・病院/クリニック/心臓病センター
・プレホスピタルセッティング
・パブリックアクセス市場
・在宅医療環境
・代替介護施設
・その他エンドユーザー
※(市場規模US$)
◆主要国地域別市場-2028年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア、韓国
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
※地域別に全セグメントの細分化データ掲載、詳細は目次参照
※国別に製品別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス（促進要因、障壁、機会、課題）
・特許分析
・バリューチェーン分析
・サプライチェーン分析
・業界構造分析
・貿易分析
・ケーススタディ分析
・競合状況
・市場シェア分析
◆除細動器の主要企業プロフィール動向
・MEDTRONIC
・STRYKER
・KONINKLIJKE PHILIPS NV
・旭化成株式会社
・BOSTON SCIENTIFIC CORPORATION
・ABBOTT
・MICROPORT SCIENTIFIC CORPORATION
・日本光電工業株式会社
・SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO, LTD
・BIOTRONIK
・CU MEDICAL SYSTEMS CO, LTD
・METSIS MEDIKAL LTD
・MEDIANA CO LTD
・PROGETTI SRL
・SCHILLER AG
・BPL MEDICAL TECHNOLOGIES
・METRAX GMBH
・MS WESTFALIA GMBH
・BEXEN CARDIO
・SHENZHEN COMEN MEDICAL INSTRUMENTS LTD
その他企業
・AVIVE SOLUTIONS INC
・AMI ITALIA
・CORPULS
・ALLIED MEDICAL LTD
・AXION CONCERN LLC
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE 30
・ FIGURE 1 MARKETS COVERED
1.3.1 GEOGRAPHIC SCOPE 30
1.3.2 YEARS CONSIDERED 31
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY RESEARCH 35
2.1.2.1 KEY DATA FROM PRIMARY SOURCES
・ FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
・ FIGURE 4 DEFIBRILLATORS MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION METHODOLOGY
・ FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 PRODUCT-BASED MARKET ESTIMATION
2.2.2 END USER-BASED MARKET ESTIMATION
・ FIGURE 6 DEFIBRILLATORS MARKET: MARKET SIZE ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
・ FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
2.4.1 RESEARCH ASSUMPTIONS
2.4.2 RESEARCH LIMITATIONS
2.5 RECESSION IMPACT
・ TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
3 EXECUTIVE SUMMARY
・ FIGURE 8 DEFIBRILLATORS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
・ FIGURE 9 DEFIBRILLATORS MARKET, BY END USER, 2023 VS. 2028
・ FIGURE 10 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2023 VS. 2028
・ FIGURE 11 GEOGRAPHICAL SNAPSHOT OF DEFIBRILLATORS MARKET
4 PREMIUM INSIGHTS
4.1 DEFIBRILLATORS MARKET OVERVIEW
・ FIGURE 12 RISING INCIDENCE OF CVD TO DRIVE MARKET
4.2 DEFIBRILLATORS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
・ FIGURE 13 IMPLANTABLE DEFIBRILLATORS TO DOMINATE MARKET DURING FORECAST PERIOD
4.3 DEFIBRILLATORS MARKET, BY REGION AND END USER
・ FIGURE 14 HOSPITALS, CLINICS, AND CARDIAC CENTERS SEGMENT IN ASIA PACIFIC REGION ACCOUNTED FOR LARGEST SHARE IN 2022 48
4.4 GEOGRAPHIC SNAPSHOT OF DEFIBRILLATORS MARKET
・ FIGURE 15 CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 16 DEFIBRILLATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES
・ TABLE 2 PERCENTAGE OF POPULATION AGED 65 YEARS, BY REGION
5.2.1.2 GROWING FOCUS ON PROVIDING PUBLIC-ACCESS DEFIBRILLATORS
5.2.1.3 TRAINING AND AWARENESS PROGRAMS ON DEFIBRILLATORS
5.2.2 RESTRAINTS
5.2.2.1 FREQUENT PRODUCT RECALLS
・ TABLE 3 RECENT PRODUCT RECALLS BY US FDA (2018–2023)
5.2.3 OPPORTUNITIES
5.2.3.1 EMERGING MARKETS
5.2.3.2 DEVELOPMENT OF S-ICDS AND MRI-COMPATIBLE ICDS & CRT-DS
5.2.4 CHALLENGES
5.2.4.1 INADEQUATE AWARENESS OF SUDDEN CARDIAC ARRESTS IN EMERGING MARKETS 55
5.2.4.2 CHALLENGES ASSOCIATED WITH PRICING PRESSURE
5.3 REIMBURSEMENT SCENARIO
・ TABLE 4 MEDICAL REIMBURSEMENT CODES FOR DEFIBRILLATOR PROCEDURES IN US
・ TABLE 5 MEDICARE OUTPATIENT: NATIONAL AVERAGE PAYMENT IN US (2023)
5.4 REGULATORY LANDSCAPE
5.4.1 US
・ TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION
・ TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.1.1 CANADA
・ TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.2 EUROPE
5.4.3 ASIA PACIFIC
5.4.3.1 CHINA
5.4.3.2 JAPAN
5.4.3.3 INDIA
・ TABLE 9 KEY REGULATORY BODIES AND GOVERNMENT AGENCIES
5.5 PRICING TREND ANALYSIS
・ TABLE 10 AVERAGE SELLING PRICE OF DEFIBRILLATORS, BY KEY PLAYER (2021) (USD)
・ TABLE 11 AVERAGE SELLING PRICE OF DEFIBRILLATORS, BY COUNTRY (USD) (2021)
5.6 PATENT ANALYSIS
・ FIGURE 17 TOP PATENT APPLICANTS FOR DEFIBRILLATORS DEVICES, JANUARY 2012–MAY 2023
5.7 VALUE CHAIN ANALYSIS
5.7.1 RESEARCH & DEVELOPMENT
5.7.2 MANUFACTURING & ASSEMBLY
5.7.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
・ FIGURE 18 DEFIBRILLATORS MARKET: VALUE CHAIN ANALYSIS
5.8 SUPPLY CHAIN ANALYSIS
・ FIGURE 19 DEFIBRILLATORS MARKET: SUPPLY CHAIN ANALYSIS
5.9 PORTER’S FIVE FORCES ANALYSIS
5.9.1 OVERVIEW
・ TABLE 12 DEFIBRILLATORS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.2 THREAT OF NEW ENTRANTS
5.9.3 THREAT OF SUBSTITUTES
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 BARGAINING POWER OF BUYERS
5.9.6 INTENSITY OF COMPETITIVE RIVALRY
5.10 TRADE ANALYSIS
・ TABLE 13 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION)
・ TABLE 14 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION)
5.11 TECHNOLOGY ANALYSIS
・ FIGURE 20 ECOSYSTEM COVERAGE
5.12 KEY CONFERENCES AND EVENTS
・ TABLE 15 DEFIBRILLATORS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2022−2023)
5.13 CASE STUDY ANALYSIS
5.13.1 IDENTIFY IMPACT OF 4-LAYER RIGID-FLEX BOARD PCB IN DEFIBRILLATORS
・ TABLE 16 CASE 1: IDENTIFY IMPACT OF THIN-LAYERED PCBS IN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
5.14 STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS 71
・ FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCTS
5.15 KEY BUYING CRITERIA
・ FIGURE 22 KEY BUYING CRITERIA FOR DEFIBRILLATORS
6 DEFIBRILLATORS MARKET, BY PRODUCT
6.1 INTRODUCTION
・ TABLE 17 DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
・ TABLE 18 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 19 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 20 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
・ TABLE 21 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
6.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
・ TABLE 22 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 23 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.1.1 BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS
6.2.1.1.1 LAUNCH OF TECHNOLOGICALLY ADVANCED CRT-D DEVICES TO DRIVE MARKET 77
・ TABLE 24 BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.1.2 DUAL-CHAMBER ICDS
6.2.1.2.1 ABILITY TO REDUCE INCIDENCE OF INAPPROPRIATE SHOCKS TO DRIVE MARKET 78
・ TABLE 25 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.1.3 SINGLE-CHAMBER ICDS
6.2.1.3.1 UTILIZATION IN ARTERIAL MONITORING TO SUPPORT MARKET GROWTH
・ TABLE 26 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
6.2.2.1 BENEFITS OF ELIMINATING CARDIAC LEADS TO DRIVE MARKET
・ TABLE 27 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3 EXTERNAL DEFIBRILLATORS
・ TABLE 28 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 29 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 30 EXTERNAL DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
・ TABLE 31 EXTERNAL DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
6.3.1 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS
6.3.1.1 INITIATIVES FOR EMERGENCY MEDICAL SERVICES TO SUPPORT MARKET GROWTH 82
・ TABLE 32 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.2 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS
6.3.2.1 RISING INSTALLATION IN PUBLIC PLACES TO PROPEL MARKET
・ TABLE 33 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS
6.3.3.1 OPERATIONAL DIFFICULTIES AND FALSE ALARMS TO RESTRAIN MARKET ADOPTION
・ TABLE 34 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
7 DEFIBRILLATORS MARKET, BY PATIENT TYPE
7.1 INTRODUCTION
・ TABLE 35 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
7.2 ADULT PATIENTS
7.2.1 INCREASING UTILIZATION OF PUBLIC-ACCESS DEFIBRILLATORS TO DRIVE MARKET
・ TABLE 36 DEFIBRILLATORS MARKET FOR ADULT PATIENTS, BY REGION, 2021–2028 (USD MILLION)
7.3 PEDIATRIC PATIENTS
7.3.1 INCREASING INCIDENCE OF PEDIATRIC HEART AILMENTS TO SUPPORT MARKET GROWTH
・ TABLE 37 DEFIBRILLATORS MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2021–2028 (USD MILLION)
8 DEFIBRILLATORS MARKET, BY END USER
8.1 INTRODUCTION
・ TABLE 38 DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS
8.2.1 HIGH VOLUME OF ICD PROCEDURES TO DRIVE MARKET
・ TABLE 39 DEFIBRILLATORS MARKET FOR HOSPITALS, CLINICS, AND CARDIAC CENTERS, BY REGION, 2021–2028 (USD MILLION)
8.3 PREHOSPITAL SETTINGS
8.3.1 RISING FUNDING FOR EMERGENCY AMBULANCE SERVICES TO DRIVE MARKET
・ TABLE 40 DEFIBRILLATORS MARKET FOR PREHOSPITAL SETTINGS, BY REGION, 2021–2028 (USD MILLION)
8.4 PUBLIC-ACCESS MARKETS
8.4.1 RISING INCIDENCE OF SUDDEN CARDIAC ARRESTS TO PROPEL MARKET
・ TABLE 41 DEFIBRILLATORS MARKET FOR PUBLIC-ACCESS MARKETS, BY REGION, 2021–2028 (USD MILLION)
8.5 HOME CARE SETTINGS
8.5.1 RISING ADOPTION OF HOME-AUTOMATED EXTERNAL DEFIBRILLATORS TO DRIVE MARKET
・ TABLE 42 DEFIBRILLATORS MARKET FOR HOME CARE SETTINGS, BY REGION, 2021–2028 (USD MILLION)
8.6 ALTERNATE CARE FACILITIES
8.6.1 INADEQUATE HEALTHCARE INFRASTRUCTURE TO LIMIT ADOPTION
・ TABLE 43 DEFIBRILLATORS MARKET FOR ALTERNATE CARE FACILITIES, BY REGION, 2021–2028 (USD MILLION)
8.7 OTHER END USERS
・ TABLE 44 DEFIBRILLATORS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
9 DEFIBRILLATORS MARKET, BY REGION
9.1 INTRODUCTION
・ TABLE 45 DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
・ FIGURE 23 NORTH AMERICA: DEFIBRILLATORS MARKET SNAPSHOT
・ TABLE 46 NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 47 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 48 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 99
・ TABLE 49 NORTH AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 99
・ TABLE 50 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 51 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
・ TABLE 52 NORTH AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 US
9.2.1.1 HIGH IMPLANT RATES OF ICDS TO DRIVE MARKET
・ TABLE 53 US: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 54 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 55 US: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 102
・ TABLE 56 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.2.2 CANADA
9.2.2.1 HIGH BURDEN OF CVDS TO SUPPORT MARKET GROWTH
・ TABLE 57 CANADA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 58 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 59 CANADA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 104
・ TABLE 60 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.2.3 NORTH AMERICA: RECESSION IMPACT
9.3 EUROPE
・ TABLE 61 EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 62 EUROPE: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 63 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 64 EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
・ TABLE 65 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 66 EUROPE: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
・ TABLE 67 EUROPE: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 ESTABLISHED HEALTHCARE SYSTEM EQUIPPED WITH ADVANCED CARDIOLOGY DEVICES TO DRIVE MARKET
・ TABLE 68 GERMANY: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 69 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 70 GERMANY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 109
・ TABLE 71 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.2 UK
9.3.2.1 RISING SUPPORT FROM GOVERNMENT & PRIVATE ORGANIZATIONS FOR ACCESSIBILITY OF DEFIBRILLATORS TO DRIVE MARKET
・ TABLE 72 UK: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 73 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 74 UK: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 USD MILLION) 111
・ TABLE 75 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 FAVORABLE GOVERNMENT INITIATIVES TO SUPPORT MARKET GROWTH
・ TABLE 76 FRANCE: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 77 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 78 FRANCE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
・ TABLE 79 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.4 ITALY
9.3.4.1 HIGH PREVALENCE OF OHCA TO DRIVE MARKET
・ TABLE 80 ITALY: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 81 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 82 ITALY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 114
・ TABLE 83 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 RISING AWARENESS INITIATIVES ON DEFIBRILLATORS TO PROPEL MARKET 115
・ TABLE 84 SPAIN: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 85 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 86 SPAIN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 116
・ TABLE 87 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.6 REST OF EUROPE
・ TABLE 88 REST OF EUROPE: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 89 REST OF EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 117
・ TABLE 90 REST OF EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 91 REST OF EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.7 EUROPE: RECESSION IMPACT
9.4 ASIA PACIFIC
・ FIGURE 24 ASIA PACIFIC: DEFIBRILLATORS MARKET SNAPSHOT
・ TABLE 92 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 93 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 94 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 120
・ TABLE 95 ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 121
・ TABLE 96 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 97 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
・ TABLE 98 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 PRESENCE OF UNIVERSAL INSURANCE SCHEME IN JAPAN TO SUPPORT MARKET GROWTH
・ TABLE 99 JAPAN: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 100 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 101 JAPAN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
・ TABLE 102 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 RISING INCIDENCE OF STROKES TO DRIVE MARKET
・ TABLE 103 CHINA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 104 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 105 CHINA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
・ TABLE 106 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.3 INDIA
9.4.3.1 GROWING ACCEPTANCE OF DEFIBRILLATORS AND INNOVATIVE PRODUCT LAUNCHES TO DRIVE MARKET
・ TABLE 107 INDIA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 108 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 109 INDIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 110 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.4 AUSTRALIA
9.4.4.1 INITIATIVES BY GOVERNMENT & PRIVATE BODIES FOR INSTALLATION OF PADS TO SUPPORT MARKET GROWTH
・ TABLE 111 AUSTRALIA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 112 AUSTRALIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 113 AUSTRALIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 129
・ TABLE 114 AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.5 SOUTH KOREA
9.4.5.1 LAUNCH OF INNOVATIVE PRODUCTS BY LOCAL PLAYERS TO PROPEL MARKET
・ TABLE 115 SOUTH KOREA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 116 SOUTH KOREA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 130
・ TABLE 117 SOUTH KOREA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 131
・ TABLE 118 SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.6 REST OF ASIA PACIFIC (ROAPAC)
・ TABLE 119 REST OF ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 120 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 132
・ TABLE 121 REST OF ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 122 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.7 ASIA PACIFIC: RECESSION IMPACT
9.5 LATIN AMERICA
・ TABLE 123 LATIN AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 124 LATIN AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 125 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 134
・ TABLE 126 LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 135
・ TABLE 127 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 128 LATIN AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
・ TABLE 129 LATIN AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 INCREASING OBESITY CASES TO SUPPORT MARKET GROWTH
・ TABLE 130 BRAZIL: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 131 BRAZIL: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 132 BRAZIL: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
・ TABLE 133 BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 HIGH PREVALENCE OF TARGET DISEASES TO SUPPORT MARKET GROWTH 138
・ TABLE 134 MEXICO: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 135 MEXICO: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 136 MEXICO: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 139
・ TABLE 137 MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
・ TABLE 138 REST OF LATIN AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 139 REST OF LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
・ TABLE 140 REST OF LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 141 REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.5.4 LATIN AMERICA: RECESSION IMPACT
9.6 MIDDLE EAST & AFRICA
9.6.1 GROWING AWARENESS INITIATIVES ON ADVANTAGES OF DEFIBRILLATORS TO SUPPORT MARKET GROWTH
・ TABLE 142 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 143 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 142
・ TABLE 144 MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 145 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 146 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
・ TABLE 147 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.1.1 STRATEGIES ADOPTED BY KEY PLAYERS
・ TABLE 148 STRATEGIES ADOPTED BY KEY PLAYERS (2019−2023)
10.2 REVENUE SHARE ANALYSIS
・ FIGURE 25 DEFIBRILLATORS MARKET: REVENUE SHARE ANALYSIS OF PLAYERS
10.3 MARKET SHARE ANALYSIS
・ FIGURE 26 DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER (2022)
・ TABLE 149 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICD) MARKET: INTENSITY OF COMPETITIVE RIVALRY
・ TABLE 150 AUTOMATED DEFIBRILLATORS MARKET: INTENSITY OF COMPETITIVE RIVALRY
10.4 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX (2022)
10.4.1 STARS
10.4.2 EMERGING LEADERS 150
10.4.3 PERVASIVE PLAYERS 150
10.4.4 PARTICIPANTS
・ FIGURE 27 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX (2022)
10.5 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
10.5.1 PROGRESSIVE COMPANIES
10.5.2 RESPONSIVE COMPANIES
10.5.3 DYNAMIC COMPANIES 152
10.5.4 STARTING BLOCKS 152
・ FIGURE 28 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS (2022)
10.6 COMPETITIVE BENCHMARKING: FOOTPRINT ANALYSIS OF LEADING PLAYERS
・ TABLE 151 DEFIBRILLATORS MARKET: COMPANY FOOTPRINT ANALYSIS
・ TABLE 152 DEFIBRILLATORS MARKET: PRODUCT FOOTPRINT ANALYSIS
・ TABLE 153 DEFIBRILLATORS MARKET: REGIONAL FOOTPRINT ANALYSIS
10.6.1 PRODUCT LAUNCHES & APPROVALS
・ TABLE 154 DEFIBRILLATORS MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2019–APRIL 2023)
10.6.2 DEALS
・ TABLE 155 DEFIBRILLATORS MARKET: KEY DEALS (JANUARY 2019–APRIL 2023)
10.6.3 OTHER DEVELOPMENTS
・ TABLE 156 DEFIBRILLATORS MARKET: OTHER DEVELOPMENTS (JANUARY 2019–APRIL 2023)
11 COMPANY PROFILES
11.1 KEY PLAYERS 159
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW)*
11.1.1 MEDTRONIC
・ TABLE 157 MEDTRONIC: BUSINESS OVERVIEW 159
・ FIGURE 29 MEDTRONIC: COMPANY SNAPSHOT (2022)
11.1.2 STRYKER
・ TABLE 158 STRYKER: BUSINESS OVERVIEW 165
・ FIGURE 30 STRYKER: COMPANY SNAPSHOT (2022)
11.1.3 KONINKLIJKE PHILIPS N.V.
・ TABLE 159 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
・ FIGURE 31 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
11.1.4 ASAHI KASEI CORPORATION
・ TABLE 160 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW
・ FIGURE 32 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022)
11.1.5 BOSTON SCIENTIFIC CORPORATION
・ TABLE 161 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
・ FIGURE 33 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
11.1.6 ABBOTT
・ TABLE 162 ABBOTT: BUSINESS OVERVIEW
・ FIGURE 34 ABBOTT: COMPANY SNAPSHOT (2022)
・ TABLE 163 PRODUCT APPROVALS
11.1.7 MICROPORT SCIENTIFIC CORPORATION
・ TABLE 164 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
・ FIGURE 35 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
・ TABLE 165 PRODUCT APPROVALS
11.1.8 NIHON KOHDEN CORPORATION
・ TABLE 166 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW
・ FIGURE 36 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022)
11.1.9 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
・ TABLE 167 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: BUSINESS OVERVIEW
・ FIGURE 37 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2021)
・ TABLE 168 PRODUCT LAUNCHES & APPROVALS
11.1.10 BIOTRONIK
・ TABLE 169 BIOTRONIK: BUSINESS OVERVIEW 192
11.1.11 CU MEDICAL SYSTEMS CO., LTD. 194
・ TABLE 170 CU MEDICAL SYSTEMS CO., LTD.: BUSINESS OVERVIEW
11.1.12 METSIS MEDIKAL LTD.
・ TABLE 171 METSIS MEDIKAL LTD: BUSINESS OVERVIEW
11.1.13 MEDIANA CO. LTD.
・ TABLE 172 MEDIANA CO. LTD.: BUSINESS OVERVIEW
11.1.14 PROGETTI SRL
・ TABLE 173 PROGETTI SRL: BUSINESS OVERVIEW
11.1.15 SCHILLER AG
・ TABLE 174 SCHILLER AG: BUSINESS OVERVIEW
11.1.16 BPL MEDICAL TECHNOLOGIES
・ TABLE 175 BPL MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW
11.1.17 METRAX GMBH
・ TABLE 176 METRAX GMBH: BUSINESS OVERVIEW
11.1.18 MS WESTFALIA GMBH
・ TABLE 177 MS WESTFALIA GMBH: BUSINESS OVERVIEW
11.1.19 BEXEN CARDIO
・ TABLE 178 BEXEN CARDIO: BUSINESS OVERVIEW
11.1.20 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.
・ TABLE 179 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.: BUSINESS OVERVIEW
* BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
11.2 OTHER PLAYERS
11.2.1 AVIVE SOLUTIONS INC.
11.2.2 AMI ITALIA
11.2.3 CORPULS
11.2.4 ALLIED MEDICAL LTD.
11.2.5 AXION CONCERN LLC 209